Skip to content

Sonja Buschow

  • PhD
  • Erasmus Medical Center
  • 14h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 997CitationsNumber of citations received by Sonja's publications. Updated daily.

Research interests

Antigen presentation; Dendritic cells; tumor Immunology; Hepatitis B virus; hepatocellular carcinoma; proteomics

About

From 1996-2002 I studied Medical Biology at Utrecht University. For my Master degree I studied GGA protein function in the group of prof. Margaret Robinson at the University of Cambridge (United Kindom) and MHC class II sorting into Multi-vesicular bodies in the Laboratory of prof. Willem Stoorvogel at the UMC Utrecht. In the latter research group I continued my scientific training studying the mechanisms of formation, secretion and targeting of Dendritic cell (DC) and B cell exosomes. After receiving my doctorate in 2006 I moved to the department of tumor Immunology at the UMC St Radboud/ NCMLS to work as a postdoctoral scientist in the group of prof. Carl Figdor. Here I used mass spectrometry and transcriptome analysis to study the molecular dynamics of phagosomes, DCs and blood cells to learn more about the optimal application of dendritic cells in cancer immunotherapy. This work already resulted in several publications describing 1) the proteomes of DC phagosomes and 2) whole DCs, 3) Semaphorin 7A as a regulator of DC migration and 4) the construction of the LFA-1 interactome. Late 2014 I continued my scientific career at the department of Gastroenterology to study antigen presentation in chronic hepatitis B (HBV) and HBV-related hepatocellular carcinoma. My final goal is to develop antigen presentation-based immunotherapy to fight these deadly conditions for which currently only limited treatment options exist. For therapy design I now aim to apply my knowledge on DCs, antigen presentation and mass spectrometry study the presentation of (viral) antigens on dendritic cells and infected and transformed hepatocytes.

Groups

Co-authors (167)

Publications (5)

  • Transcriptional patterns associated with BDCA3 expression on BDCA1 <sup>+</sup> myeloid dendritic cells

    • van der Aa E
    • Biesta P
    • Woltman A
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Differential expression of tetraspanin superfamily members in dendritic cell subsets

    • Zuidscherwoude M
    • Worah K
    • van der Schaaf A
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • HBV-derived synthetic long peptide can boost CD4+ and CD8+ T cell responses in chronic HBV patients ex vivo Running title: SLP can boost HBV-specific T cells

    • Dou Y
    • Van Montfoort N
    • Van Den Bosch A
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • PD-L1, Galectin-9 and CD8<sup>+</sup>tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma

    • Sideras K
    • Biermann K
    • Verheij J
    • et al.
    N/AReaders
    14Citations
    Get full text
  • Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1 / Raf Kinase inhibitory protein

    • Buschow S
    • Ramazzotti M
    • Reinieren-Beeren I
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Erasmus MC

Education

biochemistry and cell biology

Universiteit Utrecht

March 2002 - December 2006(5 years)